The acute bronchiolitis rebound in children after COVID-19 restrictions: a retrospective, observational analysis

Antonietta Curatola1, Benedetta Graglia2, Serena Ferretti3

  • 1. c.anto91@hotmail.it.

Insights

The post-COVID period saw an earlier, shorter bronchiolitis season with increased hospitalizations in children. Respiratory Syncytial Virus (RSV) was the most common cause, with SARS-CoV-2 rarely identified.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • Bronchiolitis is a leading cause of pediatric illness and hospitalization.
  • Understanding seasonal trends and etiology is crucial for public health management.

Purpose of the Study:

  • To compare Pediatric Emergency Department (PED) admissions for bronchiolitis during the post-COVID period with previous seasons.
  • To analyze the etiology of bronchiolitis during and after the COVID-19 pandemic.

Main Methods:

  • A comparative analysis of demographic, clinical, and microbiological data.
  • Data collected from children admitted to the PED with bronchiolitis between September 2021 and March 2022 (post-COVID period) compared to previous seasons (COVID and pre-COVID).

Main Results:

  • The post-COVID bronchiolitis season began earlier with a peak in November 2021.
  • Higher rates of high-priority codes (61.4%) and hospitalizations were observed in the post-COVID period compared to pre-COVID (34.8%).
  • Respiratory Syncytial Virus (RSV) was prevalent (60.2%), followed by Human Rhinovirus (30.1%); SARS-CoV-2 was rarely detected (1.5%).

Conclusions:

  • The post-COVID period exhibited an early, intense, and short bronchiolitis season with increased hospitalization rates.
  • SARS-CoV-2 was an infrequent cause of bronchiolitis in young children during this period.
Abstract

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.7K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
265
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
368
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
498